# The Therapeutic Effect of Thalidomide in Syringomyelia

> **NCT06268093** · PHASE2 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 30 (estimated)

## Conditions studied

- Syringomyelia
- Thalidomide

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT06268093
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02
- **Primary completion:** 2027-02
- **Final completion:** 2028-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268093, "The Therapeutic Effect of Thalidomide in Syringomyelia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06268093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*